Differences between intravenous iron products: focus on treatment of iron deficiency in chronic heart failure patients-Reference-Cited by-同舟云学术

Differences between intravenous iron products: focus on treatment of iron deficiency in chronic heart failure patients

Published:2019-01-29 Issue:2 Volume:6 Page:241-253
ISSN:2055-5822
Container-title:ESC Heart Failure
language:en
Short-container-title:ESC Heart Failure

Author:

Martin‐Malo Alejandro¹,Borchard Gerrit²,Flühmann Beat³,Mori Claudio³,Silverberg Donald⁴,Jankowska Ewa A.⁵

Affiliation:

1. Hospital Universitario Reina Sofía, Department of Nephrology, Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC)University of Córdoba Córdoba Spain

2. School of Pharmaceutical SciencesUniversity of Geneva, University of Lausanne Geneva Switzerland

3. Vifor Pharma Ltd Glattbrugg Switzerland

4. Department of NephrologySourasky Medical Center Tel Aviv Israel

5. Centre for Heart Diseases – Clinical Military Hospital Wroclaw Poland

Funder

Vifor Pharma

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ehf2.12400

Reference88 articles.

1. Iron sucrose – characteristics, efficacy and regulatory aspects of an established treatment of iron deficiency and iron-deficiency anemia in a broad range of therapeutic areas

2. Ferric carboxymaltose for the treatment of iron-deficiency anemia

3. Iron deficiency in chronic heart failure: An international pooled analysis

4. National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: Australian clinical guidelines for the management of heart failure 2018

5. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ferric carboxymaltose for iron deficiency in patients with heart failure: a systematic review and meta-analysis;Future Science OA;2024-07-09

2. Management of Iron Deficiency in Heart Failure;JACC: Heart Failure;2024-07

3. Role of intravenous iron therapy for management of perioperative anaemia: A narrative review;Perioperative Precision Medicine;2024-03-31

4. A randomized, controlled, open label non-inferiority trial of intravenous ferric carboxymaltose versus iron sucrose in patients with iron deficiency anemia in China;Frontiers of Medicine;2023-10-28

5. Improvement of exercise and functional capacity and quality of life in patients with heart failure by iron therapy;Frontiers in Cardiovascular Medicine;2023-05-22